Sinthujan Jegaskanda Selected Research

Sinthujan Jegaskanda Research Topics

23	Human Influenza (Influenza) 01/2022 - 01/2012
19	Infections 11/2021 - 01/2012
2	Virus Diseases (Viral Diseases) 01/2018 - 01/2016
2	Influenza in Birds (Avian Flu) 01/2017 - 12/2014
1	Herpes Genitalis (Genital Herpes) 11/2021
1	Caliciviridae Infections 01/2018
1	Gastroenteritis 01/2018
1	Blindness (Hysterical Blindness) 10/2017
1	Neonatal herpes 10/2017
1	Eye Diseases (Eye Disease) 10/2017
1	Herpes Labialis (Fever Blister) 10/2017
1	Eye Infections 10/2017
1	Inflammation (Inflammations) 01/2016
1	HIV Infections (HIV Infection) 02/2015
1	Primary Immunodeficiency Diseases 12/2014
1	Communicable Diseases (Infectious Diseases) 12/2014
1	Autoimmune Diseases (Autoimmune Disease) 12/2014

14	AntibodiesIBA 01/2022 - 02/2013
8	VaccinesIBA 11/2021 - 04/2013
7	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 02/2013
7	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2019 - 02/2013
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2014
6	Neutralizing AntibodiesIBA 01/2019 - 02/2013
4	AntigensIBA 11/2021 - 11/2014
4	EpitopesIBA 01/2019 - 01/2012
4	CytokinesIBA 01/2019 - 01/2012
3	NucleoproteinsIBA 01/2022 - 01/2012
3	Monoclonal AntibodiesIBA 01/2022 - 10/2017
3	Antiviral Agents (Antivirals)IBA 01/2019 - 01/2016
3	Intravenous Immunoglobulins (IVIG)FDA Link 01/2018 - 12/2014
2	Fc Receptors (Fc Receptor)IBA 01/2022 - 12/2017
2	Glycoproteins (Glycoprotein)IBA 10/2017 - 07/2014
2	Adenosine Diphosphate (ADP)IBA 01/2016 - 02/2015
1	Viral HemagglutininsIBA 01/2019
1	Interferon Type IIBA 01/2019
1	Viral AntigensIBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2018
1	RNA (Ribonucleic Acid)IBA 01/2018
1	NectinsIBA 10/2017
1	Virus ReceptorsIBA 10/2017
1	AIDS VaccinesIBA 10/2017
1	ChemokinesIBA 01/2016
1	Granzymes (Granzyme)IBA 01/2016
1	Subunit VaccinesIBA 01/2016
1	Interleukin-18 (Interleukin 18)IBA 01/2016
1	Natural Cytotoxicity Triggering Receptor 1IBA 01/2014
1	antineoplaston A10 (A 10)IBA 01/2012
1	Indicators and Reagents (Reagents)IBA 01/2012

1	Therapeutics 01/2019
1	Highly Active Antiretroviral Therapy (HAART) 02/2015